524. Assessing the Safety of an Outpatient Remdesivir Infusion Program for Patients with Severe COVID-19 in the Setting of a Pandemic Surge

BACKGROUND: (i) Remdesivir (RDV) shortens recovery time among COVID-19 patients in an inpatient setting. (ii) Treatments for outpatients diagnosed with COVID-19 are limited. (iii) In early 2021, there was a national surge in COVID-19 hospitalizations, which resulted in hospital bed and staff shortag...

Descripción completa

Detalles Bibliográficos
Autores principales: Gee, Benjamin, Cheruvanky, Anita, Faiad, Graciela, Li, Aldon, Pham, Huan, Quijada, Earl, Sun, Susan, Baghban, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644927/
http://dx.doi.org/10.1093/ofid/ofab466.723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644927/
http://dx.doi.org/10.1093/ofid/ofab466.723

Ejemplares similares